James Loerop - EVP Business Development at Anika Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Business Development
Issuer Symbol
ANIK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Loerop since 13 Feb 2025

Holdings reported by James Loerop for Anika Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5,592 $104,179 $18.63 08 Jul 2021 Direct
Restricted Stock Unit 3,000 $77,370 $25.79 08 Jul 2021 Direct Common Stock

Transactions reported by James Loerop for Anika Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.